depot nanocurcumin (Sign Path Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedepot nanocurcumin (Sign Path Pharma)
Drug Alias Namenuclear factor kappaB inhibitor (Sign Path/University of North Texas)NF-kappaB inhibitor (Sign Path Pharma/University of North Texas)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Texas Health Science Center At
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignpath PharmaUniversity Of North Texas Health Science Center At
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A